Clinical Trial Update: Effects of Dexmedetomidine on the Liver Injury After Hepatectomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether dexmedetomidine reduces liver injury after hepatectomy in the context of ischemia-reperfusion, with the study now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Ischemia-reperfusion Injury | Phase 4 | Status: COMPLETED